HDAC9 and thyroid gland undifferentiated (anaplastic) carcinoma: In a first set of experiments, single effects of the HDAC inhibitor SAHA and the PARP inhibitor PJ34 on cell viability of the human anaplastic thyroid cancer-derived cell line SW1736 were investigated.